Copanlisib is a selective phosphoinositide 3-kinase (PI3K) inhibitor used in the treatment of specific solid tumors and hematological malignancies. By targeting the PI3K signaling pathway, this compound… Read more
![Chemical structure of 2-Amino-N-(7-(methoxy-d3)-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2168537-34-4-2-Amino-N-7-methoxy-d3-8-3-morpholinopropoxy-23-dihydroimidazo12-cquinazolin-5-ylpyrimidine-5-carboxamide.png&w=3840&q=75)
![Chemical structure of 2-Amino-N-(7-methoxy-8-(3-(morpholino-d8)propoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2168537-35-5-2-Amino-N-7-methoxy-8-3-morpholino-d8propoxy-23-dihydroimidazo12-cquinazolin-5-ylpyrimidine-5-carboxamide.png&w=3840&q=75)
![Chemical structure of 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl-2,2,3,3-d4)pyrimidine-5-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2168537-44-6-2-Amino-N-7-methoxy-8-3-morpholinopropoxy-23-dihydroimidazo12-cquinazolin-5-yl-2233-d4pyrimidine-5-carboxamide.png&w=3840&q=75)
![Chemical structure of 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy-1,1,2,2,3,3-d6)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2168537-40-2-2-Amino-N-7-methoxy-8-3-morpholinopropoxy-112233-d6-23-dihydroimidazo12-cquinazolin-5-ylpyrimidine-5-carboxamide.png&w=3840&q=75)

Copanlisib is a selective phosphoinositide 3-kinase (PI3K) inhibitor used in the treatment of specific solid tumors and hematological malignancies. By targeting the PI3K signaling pathway, this compound effectively regulates cellular growth and survival to inhibit tumor progression. Analytical laboratories utilize this category of pharmaceutical reference standards to support rigorous quality control and method validation processes throughout the drug development lifecycle. The selection includes Copanlisib API, along with its specific impurities and metabolites, which are essential for accurate impurity profiling and quantitative analysis. Furthermore, researchers employ stable isotope labelled compounds, such as deuterium-labelled analogues, as high-precision internal standards in mass spectrometry workflows. These materials ensure consistent, reliable data when monitoring compound stability, assessing metabolic pathways, or performing pharmacokinetic studies during the characterization of this potent kinase inhibitor.